Literature DB >> 2106833

Differential regulation of hepatic carbonic anhydrase isozymes in the streptozotocin-diabetic rat.

S J Dodgson1, M Watford.   

Abstract

Most work with the male rat liver carbonic anhydrase isozymes in the past decade has centered on the cytosolic CA III and the mitochondrial CA V. This paper reports that the relative activity of both isozymes is altered in streptozotocin-diabetes. Carbonic anhydrase activity of perfused liver homogenates and disrupted, isolated mitochondria was measured by the mass spectrometric 18O decay technique at 37 degrees C. The contributions of the different isozymes were determined based on intracellular location and sensitivity to acetazolamide inhibition. Diabetes resulted in a twofold increase in the activity of CA V but a halving in the activity of CA III. This is the first time that liver CA V has been shown to be altered by physiological stress. The total carbonic anhydrase activity in the diabetic rat liver was unaltered compared with control rats; however, CA III never accounted for more than 50% of this activity. Since CA isozymes I, II, and IV together account for 30% of the CA activity in control rats and 70% in diabetic rats it is concluded that one or more of these isozymes is subject to regulation in the diabetic male rat. The increase in CA V during diabetes is in accord with this isozyme having an important function in provision of substrate for hepatic gluconeogenesis and ureagenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106833     DOI: 10.1016/0003-9861(90)90597-r

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Mitochondrial carbonic anhydrase in osteoclasts and two different epithelial acid-secreting cells.

Authors:  E K Karhukorpi; P Lakkakorpi; N Carter; S Dodgson; K Väänänen
Journal:  Histochem J       Date:  1992-01

2.  Acetazolamide-insensitive carbonic anhydrase activities in liver and tonic skeletal muscle of adult male rats with streptozotocin-induced diabetes mellitus.

Authors:  J B Moynihan; S Ennis
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Hepatic proteomic analysis revealed altered metabolic pathways in insulin resistant Akt1(+/-)/Akt2(-/-) mice.

Authors:  Brian A Pedersen; Weiwen Wang; Jared F Taylor; Omar S Khattab; Yu-Han Chen; Robert A Edwards; Puya G Yazdi; Ping H Wang
Journal:  Metabolism       Date:  2015-09-12       Impact factor: 8.694

4.  Opposite Expression of SPARC between the Liver and Pancreas in Streptozotocin-Induced Diabetic Rats.

Authors:  Kanikkai Raja Aseer; Sang Woo Kim; Myung-Sook Choi; Jong Won Yun
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  Astrocytic GABA transporter 1 deficit in novel SLC6A1 variants mediated epilepsy: Connected from protein destabilization to seizures in mice and humans.

Authors:  Felicia Mermer; Sarah Poliquin; Shuizhen Zhou; Xiaodong Wang; Yifeng Ding; Fei Yin; Wangzhen Shen; Juexin Wang; Kathryn Rigsby; Dong Xu; Taralynn Mack; Gerald Nwosu; Carson Flamm; Matthew Stein; Jing-Qiong Kang
Journal:  Neurobiol Dis       Date:  2022-07-14       Impact factor: 7.046

6.  Methazolamide is a new hepatic insulin sensitizer that lowers blood glucose in vivo.

Authors:  Nicky Konstantopoulos; Juan C Molero; Sean L McGee; Briana Spolding; Tim Connor; Melissa de Vries; Stephen Wanyonyi; Richard Fahey; Shona Morrison; Courtney Swinton; Sharon Jones; Adrian Cooper; Lucia Garcia-Guerra; Victoria C Foletta; Guy Krippner; Sofianos Andrikopoulos; Ken R Walder
Journal:  Diabetes       Date:  2012-05-14       Impact factor: 9.461

7.  Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice.

Authors:  Sarah W Renner; Lauren M Walker; Lawrence J Forsberg; Jonathan Z Sexton; Jay E Brenman
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

8.  Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation.

Authors:  Hiroyuki Yamamoto; Naoto Uramaru; Azusa Kawashima; Toshiyuki Higuchi
Journal:  FEBS Open Bio       Date:  2022-02-10       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.